MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
A3931 VX-11e5 CitationTarget: ERKSummary: ERK inhibitor
-
A3942 XMD17-109Target: ERKSummary: ERK-5 inhibitor
-
B1267 RefametinibTarget: MEKSummary: MEK 1/ MEK 2 inhibitor
-
B1174 LGX818Target: RafSummary: RAF inhibitor,potent and selective
-
B1106 VRT752271Target: ERKSummary: ERK1/ERK2 inhibitor
-
A8435 FurosemideTarget: Na /K /Cl- Symporters (NKCCs)|GABAA ReceptorsSummary: GABAA receptors antagonist
-
A8686 VX-745Target: p38Summary: P38α inhibitor,highly potent and selective
-
A8689 PD 169316Target: p38Summary: P38 MAPK inhibitor
-
A3004 Vemurafenib (PLX4032, RG7204)9 CitationTarget: RafSummary: BRAF kinase inhibitor
-
A3009 Sorafenib2 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor